Your browser doesn't support javascript.
loading
Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
Errazquin, Ricardo; Page, Angustias; Suñol, Anna; Segrelles, Carmen; Carrasco, Estela; Peral, Jorge; Garrido-Aranda, Alicia; Del Marro, Sonia; Ortiz, Jessica; Lorz, Corina; Minguillon, Jordi; Surralles, Jordi; Belendez, Cristina; Alvarez, Martina; Balmaña, Judith; Bravo, Ana; Ramirez, Angel; Garcia-Escudero, Ramon.
Afiliación
  • Errazquin R; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain.
  • Page A; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales
  • Suñol A; Hereditary Cancer Genetics Group and Medical Oncology Department, VHIO, Barcelona, Spain.
  • Segrelles C; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales
  • Carrasco E; Hereditary Cancer Genetics Group and Medical Oncology Department, VHIO, Barcelona, Spain.
  • Peral J; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Avenida Complutense 40, 28040 Madrid, Spain.
  • Garrido-Aranda A; Centro de Investigaciones Médico-Sanitarias (CIMES), Malaga, Spain.
  • Del Marro S; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Avenida Complutense 40, 28040 Madrid, Spain.
  • Ortiz J; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Avenida Complutense 40, 28040 Madrid, Spain.
  • Lorz C; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales
  • Minguillon J; Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; Centro de Investigación Biomédica en Enfermedades Raras (CIBERER), 28029 Madrid, Spain.
  • Surralles J; Join Research Unit on Genomic Medicine UAB-Sant Pau Biomedical Research Institute (IIB Sant Pau), Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain; Centro de Investigación Biomédica en Enfermedades Raras (CIBERER), 28029 Madrid, Spain.
  • Belendez C; Centro de Investigación Biomédica en Enfermedades Raras (CIBERER), 28029 Madrid, Spain; Pediatric Hematology and Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain; Instituto Investigación Sanitaria Gregorio Marañó
  • Alvarez M; Centro de Investigaciones Médico-Sanitarias (CIMES), Malaga, Spain.
  • Balmaña J; Hereditary Cancer Genetics Group and Medical Oncology Department, VHIO, Barcelona, Spain.
  • Bravo A; Department of Anatomy, Animal Production and Veterinary Clinical Sciences, Laboratory of Pathology Phenotyping of Genetically Engineered Mice, Faculty of Veterinary Medicine, University of Santiago de Compostela, 27002 Lugo, Spain.
  • Ramirez A; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales
  • Garcia-Escudero R; Research Institute Hospital 12 de Octubre (imas12), University Hospital "12 de Octubre", Av Córdoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medioambientales
Oral Oncol ; 134: 106184, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36191479
ABSTRACT
Fanconi anemia (FA) patients frequently develop oral squamous cell carcinoma (OSCC). This cancer in FA patients is diagnosed within the first 3-4 decades of life, very often preceded by lesions that suffer a malignant transformation. In addition, they respond poorly to current treatments due to toxicity or multiple recurrences. Translational research on new chemopreventive agents and therapeutic strategies has been unsuccessful partly due to scarcity of disease models or failure to fully reproduce the disease. Here we report that Fanca gene knockout mice (Fanca-/-) frequently display pre-malignant lesions in the oral cavity. Moreover, when these animals were crossed with animals having conditional deletion of Trp53 gene in oral mucosa (K14cre;Trp53F2-10/F2-10), they spontaneously developed OSCC with high penetrance and a median latency of less than ten months. Tumors were well differentiated and expressed markers of squamous differentiation, such as keratins K5 and K10. In conclusion, Fanca and Trp53 genes cooperate to suppress oral cancer in mice, and Fanca-/-;K14cre;Trp53F2-10/F2-10 mice constitute the first animal model of spontaneous OSCC in FA.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Anemia de Fanconi / Neoplasias de Cabeza y Cuello Límite: Animals Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Anemia de Fanconi / Neoplasias de Cabeza y Cuello Límite: Animals Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: España